Supernus Pharmaceuticals Statistics
NASDAQ: SUPNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
43.05+0.22 (+0.51%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Supernus Pharmaceuticals by the numbers
Supernus Pharmaceuticals has a market capitalization of $2.51 billion based on 58.22M shares outstanding. With trailing EPS of $-1.92, Supernus Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 3.4% below its 50-day average and 10.6% below its 200-day average.
Average daily trading volume is 769.62K shares, or about $33.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SUPN valuation vs. peer median
| Metric | SUPN | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.51B | $2.37B | +6% |
| Forward P/E | 9.7 | 8.4 | +15% |
| Avg. volume | 769.62K | 1.08M | -29% |
Peer median across 8 companies: HCM, NAMS, LQDA, NRIX, MBX, IRON, BHC, HRMY.
Valuation
- Market cap
- $2.51B
- Forward P/E
- 9.65
- EPS (TTM)
- $-1.92
- Shares outstanding
- 58.22M
Price and trading
- Previous close
- 42.83
- Open
- 42.24
- Day range
- 42.24 – 43.38
- 52-week range
- 40.51 – 59.68
- 52-week change
- -10.44%
- Beta
- —
- Volume
- 459.13K
- Average volume
- 769.62K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 2.51B
- Forward Pe
- 9.65
- Eps
- -1.92
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 59.68
- Week52 Low
- 40.51
- Avg Volume
- 769.62K
- Shares Outstanding
- 58.22M
- Ma50
- 44.58
- Ma200
- 48.15
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -27.87%
- Pct From52w Low
- 6.27%